Article Information
History
- January 23, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Rahel Ackermann-Gäumann1,2,
- Alexis Dentand3,
- Reto Lienhard1,2,
- Mohsan Saeed4,5,
- Margaret R. MacDonald6,
- Alix T Coste1,3 and
- Valeria Cagno1,3,*
- 1Swiss National Reference Centre for Tick-Transmitted Diseases, Switzerland
- 2ADMED Microbiologie, La Chaux-de-Fonds 2300, Switzerland
- 3Lausanne University Hospital, University of Lausanne, Switzerland
- 4Department of Biochemistry & Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston University, MA 02118
- 5National Emerging Infectious Diseases Laboratories, Boston University, MA 02118
- 6Laboratory of Virology and Infectious Disease, The Rockefeller University, New York NY 10065
- ↵*To whom correspondence should be addressed. Valeria Cagno, Institute of Microbiology of Lausanne Rue du Bugnon 48, 1011 Lausanne, +41213142611, valeria.cagno{at}chuv.ch
Posted January 23, 2024.
A reporter virus particle seroneutralization assay for tick-borne encephalitis virus overcomes ELISA limitations
